Telomere length and risk of glioma

Cancer Epidemiology

Volumn 37, Issue 6, 2013, Pages 935-938

  Walcott, Farzana ^a   Rajaraman, Preetha ^a   Gadalla, Shahinaz M ^a   Inskip, Peter D ^a   Purdue, Mark P ^a   Albanes, Demetrius ^a   Orr, Esther ^b   De Vivo, Immaculata ^b,c   Savage, Sharon A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Cancer risk; Epidemiology; Glioma; Telomere length

Indexed keywords

CELL DNA;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SCREENING; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GLIOMA; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; TELOMERE HOMEOSTASIS;

95% CONFIDENCE INTERVAL; CANCER RISK; CI; EPIDEMIOLOGY; GLIOMA; ODDS RATIO; OR; PLCO; PROSTATE, LUNG, COLORECTAL, AND OVARIAN CANCER SCREENING TRIAL; QPCR; QUANTITATIVE PCR; RELATIVE TELOMERE LENGTH; RTL; TELOMERE LENGTH;

AGED; CASE-CONTROL STUDIES; DNA; FEMALE; FOLLOW-UP STUDIES; GLIOMA; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; TELOMERE HOMEOSTASIS;

EID: 84888286530     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2013.10.002     Document Type: Article

References (28)

1. Wentzensen I.M., Mirabello L., Pfeiffer R.M., Savage S.A. The association of telomere length and cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2011, 20(6):1238-1250.
2. Ma H., Zhou Z., Wei S., Liu Z., Pooley K.A., Dunning A.M., et al. Shortened telomere length is associated with increased risk of cancer: a meta-analysis. PLoS ONE 2011, 6(6):e20466.
3. Shay J.W., Wright W.E. Role of telomeres and telomerase in cancer. Semin Cancer Biol 2011, 21(6):349-353.
4. Dolecek T.A., Propp J.M., Stroup N.E., Kruchko C. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009. Neuro Oncol 2012, 14(Suppl. 5):v1-v49.
5. Ries L.A.G. Cancer survival among adults: U.S. SEER program, 1988-2001, patient and tumor characteristics. SEER survival monograph 2007, 276 p. U.S. Department of Health and Human Services National Institutes of Health, National Cancer Institute, Bethesda, MD.
6. Dubrow R., Darefsky A.S. Demographic variation in incidence of adult glioma by subtype, United States, 1992-2007. BMC Cancer 2011, 11:325.
7. Bondy M.L., Scheurer M.E., Malmer B., Barnholtz-Sloan J.S., Davis F.G., Il'yasova D., et al. Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer 2008, 113(7 Suppl.):1953-1968.
8. Rajaraman P., Melin B.S., Wang Z., McKean-Cowdin R., Michaud D.S., Wang S.S., et al. Genome-wide association study of glioma and meta-analysis. Hum Genet 2012, 131(12):1877-1888.
9. Wrensch M., Jenkins R.B., Chang J.S., Yeh R.F., Xiao Y., Decker P.A., et al. Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet 2009, 41(8):905-908.
10. Walsh K.M., Rice T., Decker P.A., Kosel M.L., Kollmeyer T., Hansen H.M., et al. Genetic variants in telomerase-related genes are associated with an older age at diagnosis in glioma patients: evidence for distinct pathways of gliomagenesis. Neuro Oncol 2013, 15(8):1041-1047.
11. Walsh K.M., Rice T., Decker P.A., Kosel M.L., Kollmeyer T., Hansen H.M., et al. Genetic variants in telomerase-related genes are associated with an older age at diagnosis in glioma patients: evidence for distinct pathways of gliomagenesis. Neuro Oncol 2013, 15(8):1041-1047.
12. Mirabello L., Yu K., Kraft P., De Vivo I., Hunter D.J., Prescott J., et al. The association of telomere length and genetic variation in telomere biology genes. Hum Mutat 2010, 31(9):8-1050.
13. Bojesen S.E., Pooley K.A., Johnatty S.E., Beesley J., Michailidou K., Tyrer J.P., et al. Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet 2013, 45(4):371-384. 384e1-2.
14. Killela P.J., Reitman Z.J., Jiao Y., Bettegowda C., Agrawal N., Diaz L.A., et al. TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal. Proc Natl Acad Sci U S A 2013, 110(15):6021-6026.
15. Kheirollahi M., Mehrazin M., Kamalian N., Mehdipour P. Alterations of telomere length in human brain tumors. Med Oncol 2011, 28(3):864-870.
16. Maes L., Van Neste L., Van Damme K., Kalala J.P., De Ridder L., Bekaert S., et al. Relation between telomerase activity, hTERT and telomere length for intracranial tumours. Oncol Rep 2007, 18(6):1571-1576.
17. McDonald K.L., McDonnell J., Muntoni A., Henson J.D., Hegi M.E., von Deimling A., et al. Presence of alternative lengthening of telomeres mechanism in patients with glioblastoma identifies a less aggressive tumor type with longer survival. J Neuropathol Exp Neurol 2010, 69(7):729-736.
18. Jiao Y., Killela P.J., Reitman Z.J., Rasheed A.B., Heaphy C.M., de Wilde R.F., et al. Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas. Oncotarget 2012, 3(7):709-722.
19. Ferrandon S., Saultier P., Carras J., Battiston-Montagne P., Alphonse G., Beuve M., et al. Telomere profiling: toward glioblastoma personalized medicine. Mol Neurobiol 2013, 47(1):64-76.
20. Nguyen D.N., Heaphy C.M., de Wilde R.F., Orr B.A., Odia Y., Eberhart C.G., et al. Molecular and morphologic correlates of the alternative lengthening of telomeres phenotype in high-grade astrocytomas. Brain Pathol 2013, 23(3):237-243.
21. Prorok P.C., Andriole G.L., Bresalier R.S., Buys S.S., Chia D., Crawford E.D., et al. Design of the prostate, lung colorectal and ovarian (PLCO) cancer screening trial. Control Clin Trials 2000, 21(6 Suppl.):273S-309S.
22. McGrath M., Wong J.Y., Michaud D., Hunter D.J., De Vivo I. Telomere length, cigarette smoking, and bladder cancer risk in men and women. Cancer Epidemiol Biomarkers Prev 2007, 16(4):815-819.
23. Cawthon R.M. Telomere measurement by quantitative PCR. Nucleic Acids Res 2002, 30(10):e47.
24. Daniali L., Benetos A., Susser E., Kark J.D., Labat C., Kimura M., et al. Telomeres shorten at equivalent rates in somatic tissues of adults. Nat Commun 2013, 4:1597.
25. Gadalla S.M., Cawthon R., Giri N., Alter B.P., Savage S.A. Telomere length in blood, buccal cells, and fibroblasts from patients with inherited bone marrow failure syndromes. Aging (Albany NY) 2010, 2(11):867-874.
26. Friedrich U., Griese E., Schwab M., Fritz P., Thon K., Klotz U. Telomere length in different tissues of elderly patients. Mech Ageing Dev 2000, 119(3):89-99.
27. Weischer M., Nordestgaard B.G., Cawthon R.M., Freiberg J.J., Tybjaerg-Hansen A., Bojesen S.E. Short telomere length cancer survival, and cancer risk in 47102 individuals. J Natl Cancer Inst 2013, 105(7):459-468.
28. Willeit P., Willeit J., Mayr A., Weger S., Oberhollenzer F., Brandstatter A., et al. Telomere length and risk of incident cancer and cancer mortality. JAMA 2010, 304(1):69-75.